Targeting the CYP2B1/cyclophosphamide suicide system to fibroblast growth factor receptors results in a potent antitumoral response in pancreatic cancer models

1. Huch, M.
2. Abate-Daga, D.
3. Roig, J.M.
4. González, J.R.
5. Fabregat, J.
6. Sosnowski, B.
7. Mazo, A.
8. Fillat, C.